Filing Flows › Oscar Health (OSCR) › Q3 2026
Oscar Health (OSCR) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Oscar Health (OSCR) reported revenue of $5.1B for the third quarter 2026 (Q3 2026), +72% from a year earlier and +5% from the quarter before. Operating margin was 3.5%, net earnings $167M (3.3% of revenue).
Oscar Health, Q3 2026: revenue $5.1B (+72% year over year), operating margin 3.5%, net earnings $167M, operating cash flow −$1.2B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.1B | +5% | +72% |
| Operating profit | $178M | -54% | — |
| Net earnings | $167M | -54% | — |
| Operating cash flow | −$1.2B | -157% | — |
What changed
Revenue was $5.1B in Q3 2026, up 72% year over year and up 5% from the previous quarter.
Operating profit was $0.18B, a 3.5% margin (up 7.8 points year over year). Total costs grew 59% against revenue growth of 72%. The fastest-growing cost line was Other operating costs (+63%). Net earnings were $0.17B. The effective tax rate was 4.6%.
Operating cash flow was −$1.2B. Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $1.4B. Capital expenditures of $0.01B exceeded it, leaving free cash flow of −$1.2B.
Questions
What was Oscar Health's revenue in the third quarter 2026?
Oscar Health (OSCR) reported revenue of $5.1B for the third quarter 2026 (Q3 2026), +72% from a year earlier and +5% from the quarter before.
Was Oscar Health profitable in the third quarter 2026?
Operating profit was $178M (3.5% of revenue) and net earnings $167M.
Source: Oscar Health 10-Q on SEC EDGAR.